tirzepatide sales Eli Lilly's weight-loss therapy Mounjaro tops India drug by value in October Obesity Deep Dive: The Unparalleled

PlexusDx explains which laxatives are safe, how to prevent digestive slowdown, and when to seek medical guidance

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending

Sematrinity 2mg Pre-filled Pen is used in the treatment of Type 2 diabetes mellitus

Tirzepatide is a dual agonist that targets both GLP-1 and GIP receptors, which is why clinical trials have shown even greater weight loss over 20% of body weight in some studies compared to semaglutide's average of 15%

An abstract presented at the ADA 85th Scientific Sessions showed that obesity telemedicine plus GLP-1 therapy yielded improvements in multiple outcomes.

An endocrinologist explains how these diabetes medications and weight loss drugs differ.